The mdm2 proto-oncogene sensitizes human medullary thyroid carcinoma cells to ionizing radiation
- 4 April 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (15) , 2376-2386
- https://doi.org/10.1038/sj.onc.1205307
Abstract
We have analysed the radiation response of a human medullary thyroid carcinoma cell line (MTT), characterized by the absence of a functional p53 protein, and the consequences of MDM2 overexpression in this process. We show that the product of the mdm2 proto-oncogene is able to sensitize MTT cells to ionizing radiation. After radiation treatment, MTT cells display histograms consistent with a G2M arrest. MTT cells expressing MDM2 (MTT-mdm2) are unable to respond to DNA damage with G2M arrest, and display a high percentage of apoptosis. MTT-mdm2 cells show high levels of E2F-1 protein, suggesting that the induction of apoptosis observed upon MDM2 overexpression could be dependent on E2F-1. This observation is further supported with assays showing that E2F-1 binding to specific DNA sequences is enhanced in MTT-mdm2 cells. Likewise, transactivation of reporter constructs exclusively dependent on E2F-1 is also elevated after transfection with MDM2. This effect can be reverted by transient transfection with p19ARF. To link the expression of E2F-1 with the induction of apoptosis, we generated clonal cell lines overexpressing E2F-1. Transfection with E2F-1 results in a low number of outgrowing colonies with reduced proliferation rates, indicating that E2F-1 is deleterious for cell growth. This negative regulation correlates with an increase in the percentage of the cell population with DNA content below 2N, suggesting that E2F-1 promotes apoptosis. Finally, overexpression of E2F-1 sensitizes MTT cells to radiation exposure. We conclude that the effects observed by MDM2 overexpression could be mediated by E2F-1.The work is supported by grants from the Comunidad de Madrid (CAM 08.1/0025/ 1997), Dirección General de Ciencia y Tecnología (BMC-2001-2087) and Fundación Salud 2000 (Spain).Peer RevieweKeywords
This publication has 42 references indexed in Scilit:
- MDM2 overexpression generates a skin phenotype in both wild type and p53 null miceOncogene, 1999
- MDM2 functionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1998
- Introduction ofp53 induces cell-cycle arrest inp53-deficient human medullary-thyroid-carcinoma cellsInternational Journal of Cancer, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Point Mutation of the RetProto-oncogene in the TT Human Medullary Thyroid Carcinoma Cell LineBiochemical and Biophysical Research Communications, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- The molecular biology of medullary thyroid carcinoma. A model for cancer development and progressionPublished by American Medical Association (AMA) ,1989
- Oncogenes in Radioresistant, Noncancerous Skin Fibroblasts from a Cancer-Prone FamilyScience, 1987